Rossari Biotech Management

Management Kriterienprüfungen 4/4

Rossari Biotech CEO ist Sunil Chari , ernannt in Jan 2003, hat eine Amtszeit von 21.83 Jahren. Die jährliche Gesamtvergütung beträgt ₹12.13M , bestehend aus 100% Gehalt und 0% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 30.87% der Aktien des Unternehmens, im Wert von ₹13.25B . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5 Jahre bzw. 3.3 Jahre.

Wichtige Informationen

Sunil Chari

Geschäftsführender

₹12.1m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts100.0%
Amtszeit als Geschäftsführer21.8yrs
Eigentum des Geschäftsführers30.9%
Durchschnittliche Amtszeit des Managements5yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder3.3yrs

Jüngste Management Updates

Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Aug 17
Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Recent updates

Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Aug 17
Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Jun 14
Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

May 07
Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

May 03
Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Feb 10
One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Sep 23
Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Apr 06
Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Feb 19
Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

Feb 17
Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Feb 10
I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

Nov 24
Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Oct 12
With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Dec 17
Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

Oct 26
Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Sunil Chari im Vergleich zu den Einnahmen von Rossari Biotech verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2024n/an/a

₹1b

Jun 30 2024n/an/a

₹1b

Mar 31 2024₹12m₹12m

₹1b

Dec 31 2023n/an/a

₹1b

Sep 30 2023n/an/a

₹1b

Jun 30 2023n/an/a

₹1b

Mar 31 2023₹11m₹11m

₹1b

Dec 31 2022n/an/a

₹1b

Sep 30 2022n/an/a

₹995m

Jun 30 2022n/an/a

₹1b

Mar 31 2022₹10m₹10m

₹977m

Dec 31 2021n/an/a

₹957m

Sep 30 2021n/an/a

₹948m

Jun 30 2021n/an/a

₹892m

Mar 31 2021₹9m₹9m

₹802m

Dec 31 2020n/an/a

₹729m

Sep 30 2020n/an/a

₹695m

Jun 30 2020n/an/a

₹666m

Mar 31 2020₹8m₹7m

₹653m

Mar 31 2019₹5mn/a

₹457m

Mar 31 2018₹9mn/a

₹254m

Vergütung im Vergleich zum Markt: SunilDie Gesamtvergütung ($USD143.64K) liegt unter dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Indian ($USD271.25K).

Entschädigung vs. Einkommen: SunilDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.


Geschäftsführer

Sunil Chari (59 yo)

21.8yrs

Amtszeit

₹12,130,000

Vergütung

Mr. Sunil Srinivasan Chari serves as a Managing Director of Rossari Biotech Limited since September 26, 2019 and serves as its Director since 2009. He is a co-founder of Rossari Biotech Limited in 2003. He...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Edward Menezes
Co-Founder & Executive Chairman15.8yrs₹12.13m31.13%
₹ 13.4b
Sunil Chari
Co-Founder21.8yrs₹12.13m30.87%
₹ 13.2b
Ketan Sablok
Chief Financial Officer1.5yrskeine Datenkeine Daten
Mikhail Menezes
Director of Technicalno datakeine Daten0.24%
₹ 103.3m
Parul Gupta
Company Secretary & Compliance Officer5yrs₹1.00mkeine Daten
Sunil Nair
Chief Human Resource Officer & Head Corporate Communicationsless than a yearkeine Datenkeine Daten
Yash Chari
Director of Marketing & Business Developmentno datakeine Daten0.30%
₹ 127.9m
Puneet Arora
Chief Executive Officer of Textile Chemicals Globalno datakeine Datenkeine Daten
Prasad Gadkari
President of Manufacturingno datakeine Datenkeine Daten

5.0yrs

Durchschnittliche Betriebszugehörigkeit

49yo

Durchschnittliches Alter

Erfahrenes Management: ROSSARIDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (5 ).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Edward Menezes
Co-Founder & Executive Chairman15.8yrs₹12.13m31.13%
₹ 13.4b
Sunil Chari
Co-Founder15.8yrs₹12.13m30.87%
₹ 13.2b
Aseem Dhru
Independent Director5yrs₹2.87m0.00018%
₹ 77.3k
Annoottam Ghosh
Member of Advisory Boardno datakeine Datenkeine Daten
Vikram Gupta
Member of Advisory Boardno datakeine Datenkeine Daten
Jean Marcopoulos
Member of Advisory Boardno datakeine Datenkeine Daten
Klaus Karl
Member of Advisory Boardno datakeine Datenkeine Daten
Aparna Sharma
Non-Executive Independent Director1.5yrs₹2.93mkeine Daten
Esha Achan
Additional Non-Executive Independent Director1.1yrs₹1.13mkeine Daten
Gurudas Aras
Non- Executive Independent Directorless than a yearkeine Datenkeine Daten

3.3yrs

Durchschnittliche Betriebszugehörigkeit

59yo

Durchschnittliches Alter

Erfahrener Vorstand: ROSSARIDie Vorstandsmitglieder gelten als erfahren (3.3 Jahre durchschnittliche Amtszeit).